SCIASCIA THOMAS

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
5
Insider Sells Sum
$272,220.04

Insider Activity of SCIASCIA THOMAS

According to the SEC Form 4 filings, SCIASCIA THOMAS, being in a position of

  1. Chief Scientific Officer at Trevi Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 101369 shares for $272,220,
    over all time since 2024-05-29, has bought 0 shares, and sold 101369 shares for $272,220.

The largest sale of all time was on 2024-05-29 and amounted to 53368 shares of Trevi Therapeutics, Inc. for $136,110.

Biography of SCIASCIA THOMAS

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$272,2205100

Comparison of Insiders on Amount of Buys and Sells

2024-08-19SaleTrevi Therapeutics, Inc.
TRVI
Chief Scientific Officer
16,496
0.0227%
$2.96$48,883+11.11%
2024-08-16SaleTrevi Therapeutics, Inc.
TRVI
Chief Scientific Officer
18,660
0.0268%
$2.76$51,440+19.13%
2024-08-15SaleTrevi Therapeutics, Inc.
TRVI
Chief Scientific Officer
12,745
0.0185%
$2.79$35,513+20%
2024-08-14SaleTrevi Therapeutics, Inc.
TRVI
Chief Scientific Officer
100
0.0001%
$2.75$275+26.44%
2024-05-29SaleTrevi Therapeutics, Inc.
TRVI
Chief Scientific Officer
53,368
0.0761%
$2.55$136,110+22.05%
Total: 5
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD